07 December 2017

You Don't See This Every Day

Yes, you don't:
In the trial, treatment for 14 days with SAGE-217 was associated with a statistically significant mean reduction in the Hamilton Rating Scale for Depression (HAM-D) 17-Item total score from baseline to Day 15 (the time of the primary endpoint) of 17.6 points for SAGE-217, compared to 10.7 for placebo (p<0.0001).
[my emphasis]

Now, that's a p-value to love.

No comments: